ENTYVIO (Vedolizumab)


ENTYVIO is a prescription medicine used in adults diagnosed with Crohn’s disease or moderate to severe ulcerative colitis. It works by focusing on the GI tract to help control damaging inflammation.

As part of the body’s natural immune response, white blood cells travel to different tissues to defend against disease. Certain white blood cells are directed to enter the GI tract. In individuals with ulcerative colitis and Crohn’s disease, the increased number of these cells causes inflammation and specific symptoms. ENTYVIO works to block the movement of these gut-directed white blood cells into the GI tract, which helps to control inflammation and symptoms of UC and CD.